fluorouracil has been researched along with Gastritis in 10 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We believe this case to be the second case of radiation recall presenting as diffuse gastritis in a patient receiving capecitabine after previous treatment with XRT." | 3.73 | Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. ( Black, G; Diasio, R; Johnson, M; Russo, S; Saif, MW, 2006) |
| "Renal cell carcinoma is a common neoplasm that is often refractory to treatment." | 2.68 | A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study. ( Blumenstein, BA; Crawford, ED; Elias, L; Flanigan, RC; Goodwin, JW; Kish, J; Lowe, BA; Wade, JL, 1996) |
| "We report a patient with pancreatic cancer who developed gastrointestinal bleeding secondary to radiation recall gastritis related to erlotinib exposure." | 1.40 | Radiation recall gastritis secondary to erlotinib in a patient with pancreatic cancer. ( Graziani, C; Hegde, S; Saif, MW, 2014) |
| "A 59-year-old woman with advanced gastric cancer was treated with continuous 5-fluorouracil infusion for thirty-five days." | 1.29 | Continuous 5-fluorouracil infusion causing acute gastric mucosal lesions. ( Kano, Y; Sasagawa, M; Seki, T; Suda, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graziani, C | 1 |
| Hegde, S | 1 |
| Saif, MW | 2 |
| Chon, YE | 1 |
| Seong, J | 1 |
| Kim, BK | 1 |
| Cha, J | 1 |
| Kim, SU | 1 |
| Park, JY | 1 |
| Ahn, SH | 1 |
| Han, KH | 1 |
| Chon, CY | 1 |
| Shin, SK | 1 |
| Kim, DY | 1 |
| SHERLOCK, P | 1 |
| Harting, MT | 1 |
| Blakely, ML | 1 |
| Herzog, CE | 1 |
| Lally, KP | 1 |
| Ajani, JA | 1 |
| Andrassy, RJ | 1 |
| Black, G | 1 |
| Johnson, M | 1 |
| Russo, S | 1 |
| Diasio, R | 1 |
| Bright-Asare, P | 1 |
| Whiten, JT | 1 |
| Smith, FP | 1 |
| Schein, PS | 1 |
| Macdonald, JS | 1 |
| Woolley, PV | 1 |
| Ornitz, R | 1 |
| Rogers, C | 1 |
| Suda, K | 1 |
| Seki, T | 1 |
| Kano, Y | 1 |
| Sasagawa, M | 1 |
| Elias, L | 1 |
| Blumenstein, BA | 1 |
| Kish, J | 1 |
| Flanigan, RC | 1 |
| Wade, JL | 1 |
| Lowe, BA | 1 |
| Goodwin, JW | 1 |
| Crawford, ED | 1 |
| Yamashita, F | 1 |
| Tanaka, M | 1 |
| Fukumori, K | 1 |
| Ando, E | 1 |
| Yano, Y | 1 |
| Kato, O | 1 |
| Yamamoto, H | 1 |
| Fukuda, H | 1 |
| Kusaba, T | 1 |
| Tanikawa, K | 1 |
| Sata, M | 1 |
2 trials available for fluorouracil and Gastritis
| Article | Year |
|---|---|
A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protoc | 1996 |
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
Topics: Administration, Oral; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chronic Disease; Cross-Over | 1998 |
8 other studies available for fluorouracil and Gastritis
| Article | Year |
|---|---|
Radiation recall gastritis secondary to erlotinib in a patient with pancreatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Capecitabine; Combined Modality The | 2014 |
Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoradiotherapy; Duodenal Ulcer | 2011 |
ACUTE GASTRITIS RESULTING FROM REGIONAL INFUSION OF AN ANTIMETABOLITE.
Topics: Adenocarcinoma; Angiography; Antimetabolites; Chemotherapy, Cancer, Regional Perfusion; Diagnosis, D | 1963 |
Treatment issues in pediatric gastric adenocarcinoma.
Topics: Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Sig | 2004 |
Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Deoxycytidine; Dihyd | 2006 |
Prostaglandins, gastroduodenal ulcer and hemorrhagic gastritis.
Topics: Animals; Cimetidine; Dogs; Double-Blind Method; Female; Fluorouracil; Gastritis; Gastrointestinal He | 1984 |
Fast neutron irradiation for locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Colitis; Cost-Benefit Analysis; Energy Transfer; Esophagitis; Evaluation Studies as | 1981 |
Continuous 5-fluorouracil infusion causing acute gastric mucosal lesions.
Topics: Adenocarcinoma; Female; Fluorouracil; Gastritis; Humans; Infusions, Parenteral; Middle Aged; Stomach | 1993 |